Grantham, Mayo, Van Otterloo & Co (GMO)’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-151,153
| Closed | -$5.03M | – | 641 |
|
|
2024
Q4 | $5.03M | Buy |
151,153
+67,256
| +80% | +$2.24M | 0.02% | 302 |
|
|
2024
Q3 | $2.18M | Buy |
+83,897
| New | +$2.18M | 0.01% | 366 |
|
|
2023
Q1 | – | Sell |
-97,100
| Closed | -$1.56M | – | 720 |
|
|
2022
Q4 | $1.56M | Buy |
97,100
+75,200
| +343% | +$1.21M | 0.01% | 464 |
|
|
2022
Q3 | $343K | Buy |
21,900
+3,800
| +21% | +$59.5K | ﹤0.01% | 613 |
|
|
2022
Q2 | $377K | Buy |
+18,100
| New | +$377K | ﹤0.01% | 642 |
|
|
2018
Q3 | – | Sell |
-31,000
| Closed | -$667K | – | 539 |
|
|
2018
Q2 | $667K | Buy |
31,000
+4,700
| +18% | +$101K | ﹤0.01% | 418 |
|
|
2018
Q1 | $583K | Buy |
+26,300
| New | +$583K | ﹤0.01% | 448 |
|